Cargando…
Antivirals Against Chikungunya Virus: Is the Solution in Nature?
The worldwide outbreaks of the chikungunya virus (CHIKV) in the last years demonstrated the need for studies to screen antivirals against CHIKV. The virus was first isolated in Tanzania in 1952 and was responsible for outbreaks in Africa and Southwest Asia in subsequent years. Between 2007 and 2014,...
Autores principales: | Oliveira Silva Martins, Daniel, de Andrade Santos, Igor, Moraes de Oliveira, Débora, Riquena Grosche, Victória, Carolina Gomes Jardim, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150839/ https://www.ncbi.nlm.nih.gov/pubmed/32121393 http://dx.doi.org/10.3390/v12030272 |
Ejemplares similares
-
An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets
por: Paschoalino, Marina, et al.
Publicado: (2023) -
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020) -
Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways
por: Ruiz, Uriel Enrique Aquino, et al.
Publicado: (2022) -
Organometallic Complex Strongly Impairs Chikungunya Virus Entry to the Host Cells
por: de Oliveira, Débora Moraes, et al.
Publicado: (2020) -
Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4
por: Martins, Daniel Oliveira Silva, et al.
Publicado: (2022)